Peng Hu
Kunming University of Science and Technology(CN)Tongji University(CN)University of Shanghai for Science and Technology(CN)China Mobile (China)(CN)Shanghai Jiao Tong University(CN)Dalian Medical University(CN)First People's Hospital of Yunnan Province(CN)Second Affiliated Hospital of Chongqing Medical University(CN)Digital Science (United States)(US)Shanghai First People's Hospital(CN)The Ohio State University(US)Chongqing Medical University(CN)
Publications by Year
Research Areas
RNA modifications and cancer, Cancer-related molecular mechanisms research, RNA Research and Splicing, Sarcoma Diagnosis and Treatment, MicroRNA in disease regulation
Most-Cited Works
- → Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth(2015)323 cited
- → Transarterial Chemoembolization (TACE) plus Sorafenib Versus TACE for Intermediate or Advanced Stage Hepatocellular Carcinoma: A Meta-Analysis(2014)110 cited
- → Mitochondrial ALDH2 protects against lipopolysaccharide-induced myocardial contractile dysfunction by suppression of ER stress and autophagy(2019)88 cited
- → Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma(2019)78 cited
- → Feedback Loop Regulation of SCAP/SREBP-1 by miR-29 Modulates EGFR Signaling-Driven Glioblastoma Growth(2016)77 cited
- → The roles of lncRNA in hepatic fibrosis(2018)73 cited